Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Omninvest Vaccine Manufacturing, Researching and Trading Ltd.
ClinicalTrials.gov Identifier:
NCT01010893
First received: November 7, 2009
Last updated: May 18, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
No publications provided by Omninvest Vaccine Manufacturing, Researching and Trading Ltd.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):